Genotype-Guided Oral P2Y12 Inhibitor Therapy Reduces Cumulative Ischemic Events Following Percutaneous Coronary Intervention - A Prespecified Secondary Analysis of the TAILOR-PCI Randomised Trial
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Late-Breaking Science - Innovations in drug treatment
ESC 365 is supported by
